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Lactating cows are routinely treated at dry-off with antibiotic infusions in each quarter
for the cure and prevention of pathogenic intramammary infection, which remains the
most common disease in dairy herds. This approach is known as blanket dry-cow
therapy, usually effective for the prevention and cure of infections, but has been
shown to potentially contribute to the emergence and spreading of antibiotic resistant
bacterial strains. Exploring the use of non-antibiotic treatments coupled with selective
dry-cow therapy is necessary to reduce the risk of antibiotic resistance and potential
interference with milk microbiome balance. The impact of selective dry-cow therapy on
the physiological milk microbiome needs to be carefully evaluated. In this small-scale trial,
five healthy (no mastits, SCC <200,000 cells mL−1) second-parity cows from dry-off to
5 days after calving were sampled. For every cow, each quarter received a different
treatment: (i) bismuth salnitrate (internal teat sealant, OrbSeal®, Zoetis, Italy), front
right quarter; (ii) cephalonium dihydrate (Cepravin®, MSD, Italy), rear right quarter; (iii)
benzathine cloxacillin (Cloxalene dry, Ati, Italy), rear left quarter. No treatment was applied
to the remaining quarter (front left) which served as experimental control. For 16S rRNA
gene sequencing, bacterial DNAwas extracted from 5ml of milk samples, amplified using
the primers for the V3–V4 hypervariable regions and sequenced in one MiSeq (Illumina)
run with 2 × 250-base paired-end reads. Bacteriological results confirmed that the
quarters were all healthy. The phyla Proteobacteria, Firmicutes, and Actinobacteria were
the most abundant for all treatments and controls at all three timepoints, accounting for
over 80% of the entire milk microbiota composition. No significant differences were found
between treatments and controls in terms of the major alpha and beta diversity indexes,
revealing that antibiotic, and non-antibiotic treatments for selective dry-cow therapy did
not alter significantly the milk microbiome of dairy cows. The milk microbiota composition
showed a clear evolution over the lactation cycle, and the overall changes in the milk
microbiota diversity over the lactation cycle were mainly independent of treatments.
Keywords: dairy cows, prophylaxis, selective dry-cow therapy, antibiotics, milk microbiome, teat sealant,
cephalonium, cloxacillin
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1. INTRODUCTION
Intramammary infections (IMI) are still the disease class with the
largest prevalence in dairy cattle farms worldwide [e.g., 24.8%
of cows reported to be affected in the USA in 2013; (1)]. Given
the high prevalence and the considerable estimated cost per case
[$325–426; (2)], it has a substantial impact on the profitability
of dairy farms. The main underlying pathogens involved in
the aetiology of bovine mastitis include Gram-negative (e.g.,
Escherichia coli) and Gram-positive (e.g., Staphylococcus aureus)
bacteria (3). Consequently, antibiotics have historically had a
major role in the treatment of clinical and subclinical forms
of mastitis in dairy cattle (4). The different means for therapy
and prevention of IMI are implemented in mastitis control
programmes that are adopted on a large scale by commercial
dairy farms. The most common mastitis control protocols
include blanket dry-cow therapy (BDCT), which relies on the
antibiotic treatment of every cow during the dry period, and
selective dry-cow therapy (SDCT), which targets those animals
and specific mammary quarters that are infected and need to
be treated (5, 6). The dry period is a critical component of
the milk production cycle for two main reasons: (i) high cure
rates for IMI can be achieved (7, 8), and (ii) the rate of new
IMI is greater in the periparturient period than at any other
point during lactation (9). Growing concerns and evidence on
the development of antibiotic-resistant bacterial strains and their
spread to other livestock species and humans, with potential
zoonotic risks, are pushing the investigation and adoption of
alternative strategies (10–12). Non-antibiotic solutions include
probiotics, bacteriocins, bacteriophages, teat sealants, lactoferrin,
herbal compounds, and vaccinations (4, 13–15). For dairy herds
with a low prevalence of contagious mastitis and a consistently
low somatic cell count (SCC), SDCT is a preferable alternative
approach to mastitis control. Internal teat sealants (ITS) are a
class of non-antimicrobial products that has proven to be just as
efficacious as dry-cow therapy (DCT) in the prevention of IMI
during the dry period. ITS may provide just a physical barrier or
also inhibit bacterial growth (16). The use of an ITS in a SDCT
program ensures that all healthy quarters have some form of
protection against dry-period IMI. Studies have found that SDCT
is better than BDCT in the prevention and treatment of IMI
during the dry period and can reduce the use of antimicrobials
by 21% (6, 17, 18).
Evidence has been accumulating on the role of the udder
microbiomes (teat canal and milk) on the mammary health:
their dysbiosis has been hypothesized as a predisposing factor
for mastitis (19), in line with recent views that challenge Koch’s
“one microbe–one disease” paradigm in favor of the more
complex concept of the pathobiome as etiologic agent (20).
Mastitic quarters have been found to show higher bacterial
load and lower diversity compared to healthy quarters (21–23).
Previous works on the effect of mastitis treatments on the teat-
canal and milk microbiomes involved mastitic cows treated with
antibiotics or healthy cows under DCT with antibiotics and teat
sealant. Results showed that the udder microbiomes change with
infection and over time but appear to be resilient to therapeutic
and prophylactic antimicrobial treatments (23). Derakhshani
et al. (24) assessed the use of a penicillin-novobiocin formulation
together with teat sealant; Bonsaglia et al. (25) evaluated the effect
of a third-generation cephalosporin (ceftiofur) combined with
teat sealant, and of teat sealant alone, on the milk microbiome.
It remains to be determined whether or not other classes of
antimicrobials may have a long-lasting effect on the composition
of the udder microbiome as a whole and, specifically, of the
milk microbiome.
Considering that 3rd and 4th generation cephalosporins are
currently not recommended for veterinary use according to
EU guidelines (26), it is important to evaluate other types of
antimicrobials used in DCT and their effect on the bovine milk
microbiome, relative to antibiotic-less prophylactic strategies
and untreated controls. In this small-scale trial, we sampled
healthy cows under DCT and implemented a within-subject
experimental design based on udder quarters: each quarter
received a different treatment: cephalonium dihydrate (first-
generation cephalosporin), benzathine cloxacillin, and bismuth
subnitrate (internal teat sealant); the last quarter was left
untreated and served as experimental control. We hypothesize
that antibiotic and non-antibiotic treatments for SDCT do not
alter significantly the milk microbiome of healthy dairy cows:
this would further support the replacement of antibiotics with
teat-sealant for SDCT. We followed the microbiome research
terminology proposed by Marchesi and Ravel (27).
2. MATERIALS AND METHODS
2.1. Ethics Statements
This study was conducted on a single commercial dairy farm
in Romano di Lombardia (Bergamo, Italy), thanks to its long-
standing relationship with the University of Milan. The study
was reviewed and approved by the Ethics Committee for Animal
Welfare of the University of Milan (authorization n. 88/2019).
2.2. Animals, Treatments, and Sampling
Time
Five Holstein-Friesian cows were selected for this study from
a 140 lactating-cows dairy farm in Northern Italy, with 1
year average bulk tank somatic cell count (SCC) of 159·
103 cells mL−1 and herd milk production average of 37 L d−1.
These were all second-parity cows without any symptoms of
clinical mastitis and SCC < 200,000 cells mL−1 per lactation
based on DHIA data (Dairy Herd Information Association),
as per the study inclusion criteria. Cows had freestall housing
with cubicles bedded with pelleted straw for lactating animals
and straw during the dry period (duration in the range 54–
62 days). The herd was also prescreened using bulk tank
culture to determine whether cows were confirmed negative for
Mycoplasma spp. The animals were followed over a period of
12 weeks, and sampled at three time points: dry-off, calving
(colostrum) and 5 days in milk (5 DIM). Drying-off was abrupt.
The animals remained healthy for the entire sampling period,
without signs of clinical mastitis. During the experimental period,
cows were fed ad libitum with a silage-free mixed ration using
alfalfa hay, straw, and supplementedminerals and vitamins. After
parturition, cows were milked twice a day (3 a.m., 3 p.m.) in a
double-6 herringbone parlour.
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During the dry-off period, in each cow three of the four
quarters were treated with: (i) bismuth subnitrate (internal
teat sealant, Orbeseal R©, Zoetis, Italy), front right quarter;
(ii) cephalonium dihydrate (Cepravin R©, MSD, Italy), rear right
quarter; and (iii) benzathine cloxacillin (Cloxalene dry, Ati, Italy),
rear left quarter. No treatment was applied to the remaining
quarter (front left) which served as experimental control.
Cepravin is a first-generation semi-synthetic cephalosporin
antibiotic (cephalonium dihydrate) with activity against aerobic
Gram-positive and a few community-acquired Gram-negative
bacteria. Cephalonium is used in veterinary medicine and has
broad-spectrum activity. Cloxalene is benzathine cloxacillin,
suited for dry-off and for the treatment of subclinical Gram-
positive associated mastitis susceptible to cloxacillin [e.g., S.
aureus, Streptococcus agalactiae, Streptococcus dysgalactiae,
Streptococcus uberis, non-aureus Staphylococci (NAS),
Trueperella pyogenes]. It is also used to prevent mammary
infections that may arise during the dry period or around
calving and early lactation. From each quarter milk samples were
collected at dry-off (T1), the day of calving (T2, colostrum), and
5 DIM (T3): milk samples were collected before the afternoon
milking. Sampling was carried out following the best practices
for 16S rRNA-gene sequencing experiments (28). The sample
size (5 cows, 4 quarters, 3 timepoints) was determined as a
trade-off between ethics constraints (the fewer animals used, the
better) and statistical power calculations (80% power to detect
an effect of 0.41–0.44 standard deviations with 0.05 false positive
-α- threshold). Milk microbiome studies of comparable size have
been reported (24, 29, 30).
2.3. Milk Samples Procedures and Somatic
Cell Count
Before milk sample collection, teat ends were carefully cleaned
and disinfected with chlorhexidine and 70% alcohol in
accordance with National Mastitis Council (NMC, 2017)
recommendations for aseptic collection of milk samples. First
streams of foremilk were discharged, and then approximately
10mL of milk was collected with a sterile technique from each
teat into sterile vials. These vials were previously identified with
herd, cow number, quarter, and date. Samples were transported at
4 ◦C to the laboratory and frozen at −20 ◦C until bacteriological
assays and SCC tests were performed. The SCC was estimated
on a per-quarter basis with an automated somatic cell counter
(Bentley Somacount 150, Bentley Instrument, Chaska, MN).
Milk samples were split in two aliquots, one for bacteriology
and one for sequencing. The same procedure was performed at
all timepoints.
2.4. Bacteriological Analysis
Bacteriological milk cultures were performed at the University
of Milan following published procedures recognized by the
NMC (2017). From each sample, 10 µL of milk were spread
on blood agar plates (5% defibrinated sheep blood). Plates
were incubated aerobically at 37 ◦C and examined after
24 and 48 h. Colonies were provisionally identified based
on size, Gram stain, morphology, and hemolysis pattern.
Representative colonies were then subcultured on blood agar
plates and incubated again at 37 ◦C for 24 h to obtain
pure cultures. Catalase-negative Gram-positive cocci were
identified as Streptococci and species were differentiated by
further biochemical tests (growth in 6.5% NaCl broth, esculin
hydrolysis, fermentation of ribose, sorbitol, sucrose, and inulin).
Coagulase tube test was used to differentiate catalase-positive
gram-positive cocci as S. aureus or NAS. Gram-negative
isolates were identified using colony morphology, Gram-staining
characteristics, oxidase test, indol test, and inoculation in
Simmons citrate (Laboratorios Conda, Madrid, Spain), motility
indol ornithine, and biochemical reactions on MacConkey
(Oxoid, Basingstoke, UK). Microorganisms other than bacteria
were confirmed by microscopic appearance. Samples where three
or more pathogens grew were considered contaminated.
2.5. 16S rRNA-Gene Sequencing
For each quarter, 5mL of milk were centrifuged by using
a DNA extraction method based on the combination of a
chaotropic agent, guanidium thiocyanate, with silica particles, to
obtain bacterial cell lysis and nuclease inactivation (31). DNA
quality and quantity were assessed using a NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DE,
USA). The isolated DNAwas stored at−20 ◦C until use. Bacterial
DNA was amplified using the primers described in literature (32)
which target the V3–V4 hypervariable regions of the 16S rRNA
gene. All PCR amplifications were performed in 25 µL volume per
sample. A total of 12.5 µL of Phusion High-Fidelity Master Mix
2x (ThermoFisher Scientific, Walthem, MA, USA) and 0.2 µL
of each primer (100 µM) were added to 2 µL of genomic DNA
(5 ng µL−1). Blank controls (i.e., no DNA template added to
the reaction) were also performed. No DNA extraction negative
controls have been run. A first amplification step was performed
in an Applied Biosystem 2,700 thermal cycler (ThermoFisher
Scientific). Samples were denatured at 95 ◦C for 3min, followed
by 25 cycles with a denaturing step at 98 ◦C for 30 s, annealing
at 56 ◦C for 1min and extension at 72 ◦C for 1min, with a
final extension at 72 ◦C for 7min. Amplicons were cleaned with
Agencourt AMPure XP (Beckman, Coulter Brea, CA, USA)
and libraries were prepared following the 16S Metagenomic
Sequencing Library Preparation Protocol (Illumina, San Diego,
CA, USA). The libraries obtained were quantified by Real Time
PCR with KAPA Library Quantification Kits (Kapa Biosystems,
Inc., MA, USA), pooled in equimolar proportion and sequenced
in one MiSeq (Illumina) run with 2× 250-base paired-end reads.
The 16S rRNA gene sequences obtained from this study were
deposited in the EMBL-EBI European Nucleotide Archive (ENA)
repository with the accession number PRJEB38332.
2.6. Bioinformatics Processing
Demultiplexed paired-end reads from 16S rRNA-gene
sequencing were first checked for quality using FastQC
(33) for an initial assessment. Forward and reverse paired-end
reads were joined into single reads using the C++ program
SeqPrep (34). After joining, reads were filtered for quality based
on: (i) maximum three consecutive low-quality base calls (Phred
< 19) allowed; (ii) fraction of consecutive high-quality base calls
(Phred > 19) in a read over total read length ≥ 0.75; (iii) no “N”
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-labeled bases (missing/uncalled) allowed. Reads that did not
match all the above criteria were excluded. All remaining reads
were combined in a single FASTA file for the identification and
quantification of OTUs (operational taxonomic units). Reads
were aligned against the Greengenes closed reference sequence
collection release 13.8, with 97% cluster identity (35), applying
the CD-HIT clustering algorithm (36). A predefined taxonomy
map of reference sequences to taxonomies was then used for
taxonomic identification along the main taxa ranks down to
the genus level (domain, phylum, class, order, family, genus).
By counting the abundance of each OTU, the OTU table was
created and then grouped at each phylogenetic level. Records
belonging to OTUs with total counts lower than 10 in fewer than
2 samples were filtered out. All of the above steps, except the
FastQC reads quality check, were performed with the QIIME 1.9
open-source bioinformatics pipeline for microbiome analysis
(37). The command lines and parameters used to process 16S
rRNA-gene sequence data are detailed in Biscarini et al. (38).
2.7. Alpha and Beta Diversity
The milk microbial diversity was assessed within- (alpha
diversity) and across- (beta diversity) samples. All indices (alpha
and beta diversity) were estimated from the complete OTU
table (at the OTU level), filtered for OTUs with more than
10 total counts distributed in at least two samples. Besides the
number of observed OTUs directly counted from the OTU table,
within-sample microbial richness and diversity were estimated
using the following indices: Chao1 and ACE (Abundance-based
coverage Estimator) for richness, Shannon, Simpson, and Fisher’s
alpha for diversity (39–44), Simpson E and Pielou’s J (Shannon’s
evenness) for evenness (45). The across-sample milk microbiota
diversity was quantified by calculating Bray-Curtis dissimilarities
(46). Prior to the calculation of the Bray-Curtis dissimilarities,
OTU counts were normalized for uneven sequencing depth by
cumulative sum scaling [CSS; (47)]. Among groups (teat sealant,
cephalonium, cloxacillin, and control) and pairwise Bray-Curtis
dissimilarities were evaluated non-parametrically using the
permutational analysis of variance approach [999 permutations;
(48)]. Details on the calculation of the mentioned alpha- and
beta-diversity indices can be found in (38) (S2 Appendix).
2.8. Statistical Analysis
As a consequence of the chosen experimental design, data
were hierarchically structured with treatments nested within
individuals, and measurements repeated over time. Therefore,
observations could not be assumed to be independent from
each other, but were correlated within individual cows. This was
taken into account in the linear models used to analyse between-
group (treatments, timepoints) differences in terms of SCC, alpha
diversity indices and OTU counts; SCC data were not normally
distributed and have been log-transformed prior to the analysis.
The model had the following form:
yijk = µ+ cowj + [treatment|timepoint]k(j) + eijk (1)
where yijk is the log(SCC), alpha diversity index value or OTU
counts for record i from cow jwith treatment or timepoint k;µ is
TABLE 1 | Median somatic cell count (cells mL−1) per treatment and time-point.
Timepoint
Treatment N (x time) Dry-off Calving Early milk
Cephalonium 5 4.30× 104 1.38× 106 2.00× 104
Cloxacillin 5 1.39× 105 1.39× 106 4.60× 104
Teat sealant 5 9.50× 104 2.03× 106 7.40× 104
Control 5 1.34× 105 1.56× 106 1.89× 105
the intercept, cowj is the systematic effect of the individual cow,
[treatment|timepoint]k(j) is the effect of treatment or timepoint k
nested within cow j and eijk is the residual. Var(y) = 6 + Iσ
2
e ,
where 6 is a block diagonal matrix, with 1s on the diagonal
and the covariances σ ij between records within cows in the off-
diagonal block elements; I is the identity matrix and σ 2e is the
residual variance. To test the interaction between treatments and
timepoints, model 1 was expanded as follows:
yijkz = µ+ cowj + treatmentk(j) + timepointz(j)
+ (treatment x timepoint)kz(j) + eijkz (2)
where terms were as in model 1 with the addition of
the interaction terms (treatment x timepoint)kz(j), again nested
within individual cows. Besides correctly accounting for not
independent nested observations, multilevel models as those
in Equations (1) and (2) have the property of increasing the
power of analysis through lower between-subject variability (each
subject is its own control, fewer degrees of freedom).
2.9. Software
Reads from 16S rRNA-gene sequencing were processed with
the QIIME pipeline v. 1.9 (37), used also to estimate
most diversity indices. The ACE index and sample-base
rarefaction were estimated using own Python (https://github.
com/filippob/Rare-OTUs-ACE.git) and R (https://github.com/
filippob/sampleBasedRarefaction) scripts. Plots were generated
using the ggplot2 R package (49). Additional data handling and
analysis was performed with the R environment for statistical
computing (50).
3. RESULTS
3.1. SCC and Culture-Based Bacteriology
At the onset of the experiment themedian quarter SCC per group
was in the range 43,000 (cephalonium)–139,000 (cloxacillin)
cells mL−1. At the end of the experiment, SCC increased in
the control group (+41.0%), and decreased with the teat sealant
(−22.1%), cephalonium (−53.5%), and cloxacillin (−66.9%)
treatments (Table 1). These differences were however not
statistically significant. A physiological marked SCC increment
was observed at calving (colostrum) across all groups (up to
2,000,000 cells mL−1). Results from culture-based bacteriology
showed that the milk samples used in this study were all negative
to culture. No differences have been observed along the sampling
period and among the quarters with different treatments.
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TABLE 2 | Distinct OTUs included in the dairy cow core milk microbiome (100% of the samples).
Phylum Class Order Family Genus Avg counts
Actinobacteria Actinobacteria Actinomycetales Corynebacteriaceae Corynebacterium 347.45
Actinobacteria Actinobacteria Actinomycetales Propionibacteriaceae Propionibacterium 1201.24
Firmicutes Bacilli Bacillales Staphylococcaceae Staphylococcus 166.46
Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus 277.52
Firmicutes Bacilli Lactobacillales Streptococcaceae Lactococcus 28.40
Firmicutes Bacilli Lactobacillales Streptococcaceae Streptococcus 1901.83
Proteobacteria Alphaproteobacteria Rhizobiales Bradyrhizobiaceae Bradyrhizobium 621.75
Proteobacteria Betaproteobacteria Burkholderiales Alcaligenaceae Achromobacter 46.87
Proteobacteria Gammaproteobacteria Pseudomonadales Moraxellaceae Enhydrobacter 1373.12
Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 3280.24
Proteobacteria Betaproteobacteria Burkholderiales Alcaligenaceae 2702.20
Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae 220.06
Proteobacteria Betaproteobacteria Burkholderiales 10240.48
FIGURE 1 | Pie-charts of phylum relative abundances in the dairy cow milk microbiome over time. All data, and time point breakdown.
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3.2. Sequencing Metrics
Sequencing the V3–V4 regions of the bacterial 16S rRNA-gene
produced a total of 10,707,392 reads (joined R1-R2 paired-
end reads), with an average of 178,456 reads per sample (5
cows × 4 quarters × 3 time-points = 60 samples). After
quality filtering, 2,543,623 sequences were removed, leaving
8,163,769 sequences for subsequent analyses (76% average
retention rate, maximum 85%, minimum 61%). The average
number of sequences per treatment and time-point is reported
in Table S1: this varies from a minimum of 93,474 (± 23,020)
in the cephalonium group at dry-off to a maximum of 176,831
(± 122,987) in the cephalonium group at calving. The initial
number of OTUs identified was 11 603; after filtering out
OTUs with less than 10 counts in at least 2 samples, 4,495
distinct OTUs were left. To check whether sequencing depth
and sample size were adequate to characterize the composition
of the bovine milk microbiota, sequence-based and sample-
based rarefaction curves were generated from the OTU table
before filtering (11,603 OTUs). Sequence-based rarefaction
curves were obtained from the QIIME pipeline; the sample-
based rarefaction curve was produced with ad hoc R functions.
The observed number of OTUs detected was plotted as a
function of the number of reads (up to 40,922) in each sample
and of the number of samples (Figure S1). Both curves tend
to plateau asymptotically toward a maximum, indicating that
sequencing depth and the number of samples were adequate
to characterize the milk microbiota in the present study.
Deeper sequencing or the addition of any other samples
would likely not increase significantly the number of new
OTUs discovered.
3.3. Core Milk Microbiome
Results from culture-based bacteriology confirmed that there
were no milk samples either patently contaminated or from
infected quarters. Therefore, results from 16S rRNA-gene
sequencing from all samples could be used to characterize
the core milk microbiome in dairy cows. Nevertheless, we
can not positively exclude that a fraction of the bacterial
taxa detected from 16S rRNA-gene sequencing at very low
abundances in our milk samples could be the result of sporadic
contamination. OTUs were grouped taxonomically from the
phylum to genus level (phylum, class, order, family, genus).
The 4,495 OTUs with more than 10 counts across samples
clustered into 23 distinct phyla, 51 classes, 95 orders, 221
families, and 542 genera. Taxa with relative abundance < 0.1%
were not considered. Considering OTUs shared by 99% of the
samples, the dairy cow core milk microbiota comprised only a
small portion of the total detected OTUs (Table 2), restricted
to three phyla (Proteobacteria, Firmicutes, Actinobacteria). The
core milk microbiome featured the genera Corynebacterium,
Propionibacterium, Staphylococcus, Lactobacillus, Lactococcus,
Streptococcus, Bradyrhizobium, Achromobacter, Enhydrobacter
with a relative majority of the families Pseudomonadaceae,
Alcaligenaceae, and Streptococcaceae. In terms of relative
abundances, Figure 1 reveals that most of the reads belonged
to the phyla Proteobacteria, Firmicutes, and Actinobacteria,
which accounted for over 80% of the entire milk microbiota.
A complete list of the bacterial groups at phylum, family, and
genus level as well as their relative abundances is reported in
Table S2.
3.4. Development of the Milk Microbiome
Over Time (Dry-Off, Calving, 5 DIM)
Figures 1, 2 show the relative abundance of phyla and genera
in the milk microbiome, overall and over time (dry-off,
calving, 5 DIM). Firmicutes were found to be the most
abundant phylum in the milk microbiome during dry-off, with
Proteobacteria running up (39.3 and 36.7%, respectively), while
at calving and 5 DIM milk sampling this was reverted, with
Proteobacteria (47.9 and 46.2%) more abundant than Firmicutes
(28 and 29.2%). The third and fourth most abundant phyla
were Actinobacteria (13.9, 13.5, 10.8%) and Bacteroidetes (7.9,
5.5, 4.2%), at all timepoints. This has consequences on the
Firmicutes to Bacteroidetes ratio (F:B), which is lower at dry-
off (10.6) and higher at later time points (18.3, 22.3). Table 3
reports the 61 OTUs, at the various taxonomic levels, which
are significantly differentially abundant over time. The top
significantly different OTUs are the genera rc4-4, Saliniccocus,
Dorea, Ruminococcus, and YRC22, the families Peptococcaceae
and RF16, the orders RF39 and Chlorophyta, the phylum
Tenericutes. In all cases, the largest difference in counts was
observed at dry-off vs calving and 5 DIM. Indexes of richness
(observed number of OTUs, Chao1, ACE), evenness (Simpson
E, equitability -a.k.a. Shannon’s evenness) and combinations
thereof (Shannon’s and Simpson’s diversity indices, Fisher’s
alpha) describe the diversity of the milk microbiota. Results per
timepoint are reported in Figure 3 and Table 4: all comparisons
between time points, except for Simpson E, were statistically
significant. Figure 4 shows the first two dimensions from
the (non-metric) multi-dimensional scaling of the Bray-Curtis
dissimilarity matrix.
3.5. Effect of Mastitis Treatments
Figure 5 reports the barchart of the relative abundances of phyla
in the milk microbiome by dry-off treatment (cephalonium,
cloxacillin, teat sealant, and control). The top three most
represented phyla were the same in all treatments: Proteobacteria
(43.0, 38.4, 46.4, 49.4%), Firmicutes (31.5, 33.7, 29.7, 31.1%),
Actinobacteria (12.8, 11.9, 14.5, 10.8%). The fourth most
common phylum was Bacteroidetes in milk samples from
cephalonium (7.44%), cloxacillin (7.49%), and control (3.84%)
quarters, Cyanobacteria in teat-sealant quarters (3.58%). The
average F:B ratio was highest with teat sealant (31.6), followed
by cloxacillin (16.4), controls (12.4), and cephalonium (7.8).
Only five OTUs were significantly differentially abundant
between mastitis treatments (Table 5): the phylum Tenericutes
(p-value = 0.031), the class Mollicutes (p-value = 0.017),
the order Acholeplasmatales (p-value = 0.040), the family
Yaniellaceae (p-value = 0.036) with its genus Yaniella
(p-value = 0.036). In all cases, the highest average number
of counts was observed in quarters treated with cloxacillin.
Overall comparisons of alpha diversity indices between
treatments were not significant (Table 4). However, teat-
sealant treated quarters showed a decrease in all diversity
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FIGURE 2 | Bubble chart of relative abundances for the families and genera identified in the bovine milk microbiome from 60 samples taken from differentially treated
quarters at three timepoints (n = 5 lactating cows). Only taxa with relative abundance ≥ 1% are shown.
indices over time, when adjusting for variability at baseline
(Figure 4, right pane). The first two dimensions from the
(non-metric) multi-dimensional scaling of the Bray-Curtis
dissimilarity matrix show extensive overlap between treatments,
with no significant clustering (p-value from Permanova
is 0.157).
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TABLE 3 | OTUs with significant differential abundance between time points (alpha ≤ 0.05).
Taxon OTU Dry-off Calving 5 DIM p-value
Phylum Tenericutes 57.80 1.30 17.30 1.39e-03
Phylum Cyanobacteria 270.50 2586.15 8457.60 2.56e-02
Class Mollicutes 49.45 0.95 17.30 1.66e-03
Class Clostridia 12480.30 3593.15 2885.95 9.03e-03
Class Verruco-5 24.70 1.95 0.00 1.93e-02
Class 4C0d-2 119.00 25.40 0.05 2.01e-02
Class Chloroplast 148.40 2506.65 8450.05 2.37e-02
Class Bacteroidia 3646.05 755.60 756.25 3.14e-02
Order RF39 15.40 0.75 2.50 5.37e-05
Order Chlorophyta 1.10 545.95 1268.30 3.18e-04
order Clostridiales 12454.70 3304.15 2732.80 9.55e-03
Order Aeromonadales 325.10 17.20 32.25 1.75e-02
Order Rhodospirillales 42.05 277.95 599.15 1.88e-02
Order WCHB1-41 24.70 1.95 0.00 1.93e-02
Order YS2 119.00 25.40 0.05 2.01e-02
Order Bacteroidales 3646.05 755.60 756.25 3.14e-02
Order Anaeroplasmatales 16.90 0.05 0.00 3.74e-02
Order Streptophyta 107.45 1959.00 7178.40 3.83e-02
Family Peptococcaceae 75.85 7.65 5.00 2.52e-05
Family RF16 185.40 18.05 27.20 1.35e-03
Family Clostridiaceae 1740.15 709.35 384.25 1.86e-03
Family S24-7 189.95 40.20 3.80 4.12e-03
Family Ruminococcaceae 4620.30 881.80 733.45 9.30e-03
Family Lachnospiraceae 2374.00 327.95 450.35 9.47e-03
Family Moraxellaceae 2245.30 2558.45 6109.85 1.36e-02
Family Rhodospirillaceae 31.35 267.65 592.85 1.74e-02
Family RFP12 24.70 1.95 0.00 1.93e-02
Family p-2534-18B5 15.80 1.40 0.15 2.10e-02
Family Carnobacteriaceae 160.35 95.05 353.90 2.13e-02
Family Peptostreptococcaceae 460.85 91.25 144.20 2.17e-02
Family Succinivibrionaceae 323.00 7.05 28.40 2.40e-02
Family Rikenellaceae 349.95 61.75 85.25 3.15e-02
Family Bacteroidaceae 1261.20 329.30 244.50 3.16e-02
Family Anaeroplasmataceae 16.90 0.05 0.00 3.74e-02
Genus rc4-4 70.10 6.90 0.05 6.46e-06
Genus Salinicoccus 34.90 0.00 0.50 4.63e-05
Genus Dorea 267.80 26.40 25.30 4.91e-05
Genus Ruminococcus 275.20 50.10 21.95 7.89e-04
Genus YRC22 82.90 8.50 3.05 7.93e-04
Genus Succinivibrio 145.50 4.25 18.50 1.54e-03
Genus Alloiococcus 78.75 10.10 7.20 2.30e-03
Genus GW-34 26.20 0.00 0.80 2.66e-03
Genus Mogibacterium 13.90 4.20 0.65 5.32e-03
Genus [Clostridium] 121.20 22.10 37.10 7.77e-03
Genus SMB53 768.40 336.95 183.80 8.80e-03
Genus Limnohabitans 0.45 2.20 26.45 9.91e-03
Genus Helcococcus 14.75 0.05 0.00 1.38e-02
genus Polaromonas 0.00 2.30 29.70 1.45e-02
Genus Epulopiscium 91.05 21.25 1.00 1.46e-02
Genus Phascolarctobacterium 989.60 288.30 132.85 1.79e-02
(Continued)
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TABLE 3 | Continued
Taxon OTU Dry-off Calving 5 DIM p-value
Genus Roseburia 51.90 3.10 15.80 2.16e-02
Genus Butyrivibrio 448.50 108.40 160.55 2.24e-02
Genus Clostridium 159.15 63.90 41.00 2.28e-02
Genus Propionicimonas 38.55 1.00 0.20 2.98e-02
Genus Coprococcus 153.25 28.35 40.10 3.03e-02
Genus 5-7N15 1084.85 225.20 220.15 3.16e-02
Genus Anaerostipes 92.35 4.85 26.75 3.36e-02
Genus Ruminobacter 165.80 0.50 5.15 4.32e-02
Genus [Ruminococcus] 67.35 12.60 20.10 4.47e-02
Genus Erythrobacter 5.90 27.90 2.65 4.63e-02
Genus Rummeliibacillus 370.80 84.35 135.55 4.90e-02
Taxonomic level, specific OTU, counts at dry-off, calving, and 5 DIM, p-value.
4. DISCUSSION
In this paper, the effect on the milk microbiome of different
treatments for mastitis prevention applied during the dry-
off period has been investigated. Specifically, the antibiotics
cephalonium and cloxacillin have been tested against a non-
antibiotic treatment based on the application of an internal
teat sealant, on a quarter by quarter basis. Untreated quarters
were included in the experimental design as controls. Exploring
non-antibiotic alternative options for the prevention of IMI at
dry-off in dairy cows is a current research topic of paramount
importance in the reduction of widespread antibiotic use in
livestock, thereby contributing to alleviate issues related to
antibiotic-resistant bacterial strains in veterinary and human
medicine (11, 51).
The most interesting results on how the milk microbiome is
altered in response to mastitis-prevention treatments are hereby
discussed, together with insights into the general composition of
the milk microbiome in dairy cows, and its development over the
physiological status of lactating animals.
4.1. The Milk Microbiome in Response to
Treatments
Two antibiotic (cephalonium and cloxacillin) and one non-
antibiotic (teat sealant) treatments were compared in this study
for their effect on the milk microbiome in Holstein-Friesian dairy
cows. The most abundant phyla were consistently Proteobacteria,
Firmicutes, and Actinobacteria, in this order, across treatments
and controls. No significant differences were found between
treatments and controls in terms of the major alpha and
beta diversity indexes and OTU abundances (only 5 OTUs
significantly different between treatments, Table 5). This is in
line with similar findings from studies on DCT treatments and
the milk microbiome: in clinically healthy Holstein-Friesian
cows, Derakhshani et al. (24) found no differences in alpha
diversity indices before and after BDCT treatment (combination
of penicillin G and novobiocin, plus teat sealant), except for
Chao1 (higher richness before BDCT than after), although in
their study the effect of treatment was confounded with time
(dry-off, calving). Bonsaglia et al. (25) also found no significant
effect on the milk microbiome of DCT with either antibiotic
(ceftiofur) plus teat sealant or teat sealant alone. The use of ITS
does not lead to higher infection rates compared to antibiotics
in DCT and at the same time appears to be neutral with respect
to the milk microbiome (no differences between antibiotics, ITS,
and controls): this justifies the replacement of antibiotics with
ITS for DCT, which helps reduce the use of antimicrobials in
dairy farms.
To reduce confounding from individual variability at the first
sampling time (dry-off), alpha diversity indices were adjusted
for baseline effect by removing the average values at dry-off
(Figure 3, right pane): teat-sealant quarters appear to have lower
adjusted diversity (except for Simpson’s indices and equitability)
compared to the two antimicrobial treatments and controls at
calving and 5 DIM. Bonsaglia et al. (25) also found lower Chao1
and Shannon indices at DIM 7 with teat sealant compared
to the combination of antibiotic plus teat sealant, though not
significant. Bismuth subnitrate products not only act as a physical
barrier, but also show inhibitory effect on bacterial growth
(16): this can partially explain the efficacy of bismuth-based
formulations in the prevention of intramammary infections over
the dry period. Other products have been tested as teat sealants
for their physical-barrier action, like wax plugs or intramammary
polystyrene devices, but were unsuccessful in the long-term
protection of cows against IMI and mastitis (52–54).
Contrary to expectations, antibiotic treatments did not cause
a marked reduction of the milk microbiome diversity and
bacterial counts, as reported also by previous publications
(23, 25). This may be related to the specificity of the chosen
antimicrobials, which targeted pathogens while leaving the rest
of the microbiome practically unaltered [e.g., reduction of
Enterobacteriaceae upon treatment with ceftiofur in the study of
(23)]. Additional factors that can explain any differences between
the results reported here and those found in literature include the
study design, the time of sampling, the status of cows enrolled in
the experiment, the libraries used for 16S rRNA-gene sequencing.
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FIGURE 3 | Alpha diversity indices over time and per treatment. Raw values on the left pane (NO_ADJ), values adjusted for baseline on the right pane (BSL_ADJ).
Solid lines are the average values per treatment and timepoint.
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4.2. Core Milk Microbiome and Lactation
Cycle
Table 2 and Figures 1, 2 offer a description of the milk
microbiome in Holstein Friesian cows and of how it evolves
over the lactation cycle. The core milk microbiome was
defined as OTU shared by 99% of the samples (all): among
genera usually associated with the milk milieu (Lactobacillus,
Lactococcus, Propionibacterium), this includes also bacterial
taxa commonly regarded as mastitis pathogens (Staphylococcus,
Pseudomonas, Streptococcus). Similar findings have been reported
in previous studies on the bovine milk microbiome (55). The
most abundant taxa detected in the milk microbiota are the
phyla Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes,
Cyanobacteria, Planctomycetes, the families Pseudomonadaceae,
Streptococcaceae, Propionibacteriaceae, Lactobacillaceae,
Moraxellaceae, Alcaligenaceae, Ruminococcaceae, and the genera
Pseudomonas, Streptococcus, Propionibacterium, Lactobacillus,
Corynebacterium, Acinetobacter. Proteobacteria, Firmicutes,
and Actinobacteria accounted for over 80% of the entire milk
microbiota. These results are in agreement with the composition
of the healthy milk microbiome previously reported in literature
[see (55) for a review]. The milk microbiome from cows with
clinical or subclinical mastitis is known to have lower alpha
diversity and a different composition (22, 23). In Gram-negative
mastitis, for instance, there is a higher relative abundance
of Proteobacteria in the milk microbiome, specifically, of
Enterobacteriaceae [over 60%, (23)]: in the present study, the
relative abundance of Enterobacteriaceae was < 1% at all
timepoints (except for control quarters at calving, where it went
up to∼ 20%).
The milk microbiome showed a clear evolution over the
lactation cycle -dry-off, calving (colostrum) and 5 DIM- as
indicated by the distinct clustering of Bray-Curtis distances,
which showed progressive separation from dry-off to calving
and then to 5 DIM, and by the significantly different diversity
indices between timepoints. In total, 61 OTU showed significant
differences in abundance over time. As already reported by
Derakhshani et al. (24), the family Clostridiaceae and the genus
Butyrivibrio were significantly overrepresented in pre-DCT milk
(dry-off, Table 3). In most cases (50 out of 61), these OTU were
more abundant at dry-off (beginning of the experiment) than at
subsequent timepoints (Figure 6). The transition from colostrum
to mature milk comes along with shifts in the composition
of mammary secretions, and some milk components, like
milk oligosaccharides, can affect the composition of the milk
microbiome (55). In humans, the milk microbiota composition
has been reported to be related to host factors like BMI (body
mass index) (56): in cattle, body condition (e.g., as measured
by BCS: body condition score) is known to change profoundly
from dry-off to early lactation, as a consequence of the major
physiological changes associated with parturition and the onset of
milk production, and it is therefore plausible that it can likewise
influence the milk microbiome.
All alpha diversity indices differ significantly between
timepoints (except Simpson’s E), while the interaction term
(timepoint × treatment) was never significant (Table 4, alpha
Frontiers in Veterinary Science | www.frontiersin.org 11 September 2020 | Volume 7 | Article 581
Biscarini et al. Dry-Cow Therapy and Milk Microbiome
FIGURE 4 | First two dimensions from the (non-metric) multi-dimensional scaling of the Bray-Curtis dissimilarity matrix. Samples were grouped by experimental units:
by treatment on the left pane, by timepoint on the right pane. PERMANOVA among treatments p-value = 0.157, PERMANOVA among timepoints p-value = 0.001
(using 999 permutations).
TABLE 5 | OTUs with significant differential abundance between treatments (alpha ≤ 0.05).
Taxon OTU Cephalonium Cloxacillin Teat-sealant Controls p-value
Phylum Tenericutes 11.93 59.87 12.33 17.73 3.06e-02
Class Mollicutes 10.87 54.00 10.07 15.33 1.70e-02
Order Acholeplasmatales 6.13 31.27 2.20 3.20 4.04e-02
Family Yaniellaceae 129.40 192.87 24.93 21.93 3.64e-02
Genus Yaniella 129.40 192.87 24.93 21.93 3.64e-02
Taxonomic level, specific OTU, counts in quarters treated with cepravin, cloxalene, teat-sealant or controls, p-value.
diversity) indicating that overall changes in the milk microbiota
diversity over the lactation cycle were independent of treatments.
However, the fact that significantly different OTUs were more
abundant at the beginning of the experiment (dry-off) may
hint at a possible effect of treatments on the depletion of
specific microbial taxa, in addition (or in combination) to the
physiological influence of the lactation cycle.
When looking at phyla, a shift from Firmicutes to
Proteobacteria as the most abundant phylum was observed
between dry-off vs calving and 5 DIM. This is reflected in the
evolution of the Firmicutes:Bacteroidetes (F:B) ratio, which
increased with time. The F:B ratio has been used to describe the
shift in the gut microbiota associated with aging in humans (57),
where it has been reported to increase with time, as found in the
present study but on a different timespan. More importantly,
the F:B ratio in the gut microbiota is known to play a role in
adipogenesis: in studies on obesity in mice and humans, it has
been related to higher blood and tissue fat (58, 59), although
cause/effect remains unresolved. In Holstein-Friesian cows,
Jami et al. (60) observed a strong positive correlation between
the F:B ratio in the rumen microbiota and milk-fat yield: this
latter finding is mirrored in this study, where a higher F:B
ratio has been found in the milk microbiome at the onset of
milk production (calving and 5 DIM), when a sharp increase
in fat anabolism in the mammary gland takes place. A yet
unresolved but interesting question is whether the parallel
association between increased F:B ratio and milk yield in both
the rumen and milk microbiota is linked to the role of common
metabolic pathways in the biosynthesis of fatty acids or, on
the other hand, points to interconnections between the two
microbial communities.
4.3. Implications for the Dry-Cow Therapy
Selective dry-cow therapy (SDCT) consists of treating with
antimicrobials only cows with IMI, while non-antibiotic
treatments are used on healthy cows. Since 80% of the antibiotics
used in dairy farming are used to treat mastitis (23, 61), the
adoption of SDCT over BCDT is bound to have a large global
effect and can help reduce the spread of antimicrobials resistance
(62). Teat sealants are among the non-antibiotic treatments
commonly used for SDCT, and it is relevant to assess their impact
on the milk microbiome relative to BDCT. Bonsaglia et al. (25)
Frontiers in Veterinary Science | www.frontiersin.org 12 September 2020 | Volume 7 | Article 581
Biscarini et al. Dry-Cow Therapy and Milk Microbiome
FIGURE 5 | Bar-charts of phylum relative abundances in the dairy cow milk microbiome between mastitis treatments: cephalonium, cloxacillin, teat sealant, controls.
already suggested that cows screened as negative for mastitis
during lactation can be managed at dry-off with teat sealant alone
without detrimental effects on milk microbiome and bacterial
load at first week postpartum. Similar results have been found in
the present study, where antimicrobials were directly compared
to teat sealant alone rather than in combination, with the added
value of testing a first-generation cephalosporin rather than, as
did previous works (23, 25), third-generation cephalosporins
which are currently not recommended for veterinary use in EU.
Our study included cows with low SCC (<200,000 cells mL−1)
along the whole lactation and without IMI before dry-off, and
we found no differences in the prevalence of IMI after calving
between quarters treated with different DCT antibiotics and
quarters treated only with ITS. ITS play a key role in the success
of SDCT programs and their use is highly recommended to
achieve good results (7, 63). Importantly, we found no significant
differences in the milk microbiome between DCT treatments
with antibiotics or ITS. It is however important to be aware of
the potential limitations of the present study, which include: (i)
the sample size (5 cows, although the statistical power has been
increased by adopting a nested quarter-based design); (ii) results
are directly applicable only to Holstein-Frisian second-parity
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FIGURE 6 | Heatmap of bacterial counts at different timepoints for OTUs found to be significantly different over the lactation cycle. phy.: phylum.
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cows; (iii) cows were sampled from a single intensive-farming
herd in Northern Italy.
Summarizing, the milk microbiomes of healthy dairy cows
prophylactically treated with either antibiotics or teat sealants
did not show significant differences within 5 DIM from calving.
Combined with the analogous efficacy for mastitis prevention
and the reduction in the use of antimicrobials, this further
supports the adoption of teat sealants as replacement of antibiotic
prophylaxis (BDCT) in healthy cows.
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